STOCKS TELEGRAPH

Tag: ISR

  • Isoray, Inc. (ISR) Stock Rallying in Early Trades: The Reason Being Successful Cesium-131 Results.

    Isoray, Inc. (ISR) is the manufacturer of Cesium Blu or Cesium-131 brachytherapy seeds. It develops and markets isotope-based products for treating different types of cancers. Cesium Blu is utilized for the treatment of prostate, head, lungs, colorectal and pelvic-related cancer.

    The price of ISR stock in the early trading on March 2, 2022, was last checked to be $0.35 with a surge of 3.82%.

    ISR: Events and Happenings

    On March 02, 2022, ISR announced that the researchers from Pittsburgh University’s School of Medicine have publicized a research study that determined the outstanding results on prostate cancer patients. The patients were treated with Cesium- Blu. The peer-reviewed publication titled ‘Treatment of prostate cancer with Cs-131: Long term results from a single institution’, was published in BRACHYTHERAPY.

    ISR: Key Financials

    On February 8, 2022, ISR released its consolidated financial statement for the second fiscal quarter of 2022 ended December 31, 2021. Some of the key features are discussed below.

    Revenue

    Revenue in Q2 2022 was $2.82 million comparable to $2.36 million in the prior-year period. The company observed a development of 19% in revenue over the year. Also, it topped the revenue estimates by $16 thousand.

    EPS

    Net loss per basic and diluted share in Q2 2022 was $1.60 million or $0.01 comparable to the previous year when it was $0.87 million or $0.01. The company observed a slight increase in its net loss over the year. The company’s EPS estimates were in-line with the analysts’ expectations.

    On September 28, 2021, ISR reported that The American Brachytherapy Society had recognized its Cesium Blu in its consensus statement on the low dose rate of prostate brachytherapy. This was the first time Cesium Blu was included in ABS’s consensus guidelines.

    Conclusion

    ISR stock is 74% down from the same period of 2021 as the companies were hit by the financial regressions as a result of the pandemic. Recently the company reported positive outcomes from the research of Cesium Blu on the patients. Therefore, it’s stock inclined in Wednesday’s early trading. Also, it expects revenue of $3 million against -$0.01 EPS in the third quarter of 2022.

  • Isoray Inc (ISR) stock lost 6.54% in the after-market. Here’s why

    Isoray Inc (ISR) stock lost 6.54% in the after-market. Here’s why

    The stock of Isoray Inc (ISR) closed the recent trading session at $0.35, 3.76% more than the previous trading session. On the last check, the stock of ISR remained bearish in the after-market, losing 6.54% to $0.33. Isoray published the performance for the Q2 of the financial year 2022. Isoray also filed form 8-K with the SEC on February 08, 2022. The Form 8-K is referred to the declaration of quarterly financial performance.

    ISR Q2 of FY22

    Isoray Inc published the performance of Q2 of FY22 on 08 February 2022. The Q2 concluded on 31 December 2021. The main points are

    • The sales of ISR expanded by 19% from $2.36 million in Q2 of FY21 to $2.82 million in Q2 of FY22.
    • Also, the financial gain grew by 4.5%. The profit in Q2 of FY22 was $1.22 million against to $1.17 in the quarter year-ago.
    • Moreover, the operating cost also expanded by 40% from $2.4 million in Q2 of fiscal 2021 versus $2.86 million in Q2 of fiscal 2022.
    • Further, Isoray reported a total loss of $1.60 million in Q2 of FY22 versus $0.87 million in Q2 of FY21.
    • The diluted loss of $0.01 per share.
    • Also, the stockholders’ equity at the end of Q2 of FY22 was $64.4 million.
    • ISR concentrates on prostrate brachytherapy. The sales for prostrate therapy in Q2 of FY22 grew by 13%.

    CEO Remarks

    The CEO of Isoray Inc (ISR), Lori Woods, commented that this quarter addresses the third consecutive quarter of YoY growth. Further, she stated that they are convinced that the procedures they have been executing are working and will keep on having a positive effect.

    Moreover, Ms. Wood concluded that Isoray is very much situated to speed up its development as markets bounce back from the continuous impacts of the pandemic.

    About ISR

    Isoray Inc. is a clinical organization and the sole maker of Cesium brachytherapy, which is growing brachytherapy therapy to treat malignant growths. ISR has a market capitalization of $50.11 million with 141.92 million shares pending. The company has its headquarter in Richland, Washington, United States of America (USA).

  • Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Early Morning Vibes: Top 4 Stocks To Buy Right Now

    The session on February 8, American stock markets ended in the green zone. The S&P 500 index rose 0.74% to 3916 points, the Dow Jones rose 0.76% and the NASDAQ surged 0.57%. All three indices renewed their all-time highs. The growing prospects for a major economic support package in the US remain in focus. The energy sector climbed 4.17% on the back of an ongoing rally in oil. Increased risk appetite triggered a 0.78% correction in the defensive utility sector.

    Company news

    Children’s goods maker Hasbro (HAS: -4.3%) beat expectations, but management noted weak holiday sales.

    Palantir (PLTR: + 5.9%) announced a partnership with IBM (IBM: + 1.5%) to develop technology products.

    Tesla (TSLA: + 1.3%) invested $ 1.5 billion in bitcoin and announced that it will accept cryptocurrency as payment for electric cars.

    Today, global stock markets are showing mixed dynamics. Discussions on the fiscal stimulus package remain in the spotlight. The passage of a bill on public spending in the amount of about $ 1.9 trillion threatens to accelerate inflation. Some experts warn about this, in particular, former Treasury Secretary Larry Summers. Investors in the debt market are reacting to this risk, so the day before, the rate on 30-year Treasuries rose above 2% for the first time in a year. Rising bond rates could put pressure on the attractiveness of the stock market, primarily on growth stocks, of which tech companies are prime examples.

    The epidemiological situation in the United States continues to improve rapidly, despite the circulation of new strains of coronavirus. The number of hospitalized people dropped to 80 thousand, more than 10% of Americans have already received the first dose of the vaccine. However, the risk of another jump in the incidence remains, so the CDC is not yet recommending state authorities to remove the antiquated restrictions.

    Technical picture

    Technically, the S&P 500 is still in a medium-term uptrend. The session ended the day before at the upper trend line, which is still a significant obstacle. The S & P500 index recorded growth for the sixth session in a row, so short-term consolidation is likely.

    Today Top Movers

    Iterum Therapeutics PLC (ITRM) stock ascended 61.69% at $2.04 in the pre-market trading today.‎‎ Ra Capital Management reportedly disclosed ownership of 13,730,376 shares of Iterum Therapeutics plc by filing a 13G form with the Securities and Exchange Commission. 

    ‎Assertio Therapeutics Inc (ASRT) gained over 25.24% at $1.29 in pre-market ‎trading on Tuesday.‎‎ Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. 

    ‎Aurora Mobile Ltd (JG) grew over 13.91% at $6.55 in pre-market trading ‎today following the receipt of the InfoQ 2020 Best Technology Community Award at the Developer Ecosystem Co-creation Program virtual conference, hosted by InfoQ.‎

    ‎Marathon Patent Group Inc (MARA) stock moved up 16.93 percent to $37.50 in the pre-market ‎trading.‎‎ MARA stock is rallying because of the spike in Bitcoin. Marathon Patent Group bills itself as one of the largest Bitcoin self-mining companies.

    Top Upgrades & Downgrades

    JP Morgan turned bullish on KKR Real Estate Finance Trust Inc. (KREF), upgrading the stock to “Overweight”.

    Twilio Inc. (TWLO) has won the favor of JP Morgan’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $465.0, suggesting a 1.39% additional upside for the stock. 

    The Community Financial Corporation (TCFC) received an upgrade from analysts at Piper Sandler, who also set their one-year price target on the stock to $34.0. They changed their rating on TCFC to Overweight from Neutral in a recently issued research note. 

    Earlier Tuesday JP Morgan reduced its rating on Ladder Capital Corp (LADR) stock to Underweight from Neutral and assigned the price target to $10. 

    Needham analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Cubic Corporation (CUB) has been changed to Hold from Buy.

    Latest Insider Activity

    Advanced Micro Devices Inc. (AMD) EVP, Computing & Graphics Bergman Rick announced the sale of shares taking place on Feb 04 at $88.29 for some 2,000 shares. The total came to more than $0.18 million. 

    Facebook Inc. (FB) COB and CEO Zuckerberg Mark sold on Feb 05 a total of 44,750 shares at $267.92 on average. The insider’s sale generated proceeds of almost $11.99 million. 

    Accuray Incorporated (ARAY) Director WHITTERS JOSEPH E declared the purchase of shares taking place on Feb 01 at $5.02 for some 20,000 shares. The transaction amount was around $0.1 million. 

    Consolidated Edison Inc. (ED) President & CEO CET Nachmias Stuart bought on Jan 31 a total 1,078 shares at $70.78 on average. The purchase cost the insider an estimated $667.

    Important Earnings

    Top US earnings releases scheduled for today include Cisco Systems Inc. (NASDAQ: CSCO). It will announce its Jan 2021 financial results. The company is expected to report earnings of $0.76 per share from revenues of $11.92B in the three-month period. 

    Analysts expect Isoray Inc. (AMEX: ISR) to report a net income (adjusted) of -$0.01 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $2.39M. 

    Twitter Inc. (TWTR), due to announce earnings after the market closes today, is expected to report earnings of $0.31 per share from revenues of $1.19B recently concluded three-month period.

  • Early Morning Vibes: Watch These 4 Stocks Today

    Early Morning Vibes: Watch These 4 Stocks Today

    Key US stock index futures are mostly lower on Wednesday, while traders await the results of the US Senate elections and the announcement of the official results of the presidential elections in the country, trading data showed.

    Future for the Dow Jones Industrial Average (DJIA) grew by 0.13% – to 30325 points, on the NASDAQ high-tech index – decreased by 2.19%, to 12,513.88 points, on the broad market S&P 500 index – by 0.51%, to 3699.38 points.

    Investors are closely following the US Senate elections. According to NBC News, Democrat Rafael Warnock wins the second round of Senate elections in the US state of Georgia. Democrats need to win both Senate seats from Georgia in order to gain control of the US Senate after the House of Representatives and strengthen the capacity of the future Joe Biden administration to conduct domestic politics.

    At the same time, analysts believe that the victory of the Democrats in the Senate elections could have a positive effect on the market. The “Blue Wave” (Senate Democratic advantage – ed.) Could be a good outcome for the markets as strong stimulus measures will help accelerate the economic recovery, “said Vasu Menon, senior investment strategist at OCBC Bank Wealth Management, whose opinion also leads the agency.

    Today Top Movers

    Aurora Cannabis Inc (ACB), a Drug Manufacturer company, soared about 17.94% ‎at $11.44 in pre-market trading Wednesday.‎

    Sundial Growers Inc (SNDL) share price jumped 23.56% to $0.67 during early morning ‎trading session on Wednesday.‎

    9 Meters Biopharma Inc (NMTR) stock increased 25.23% at $1.34 in the pre-‎market trading today.

    IsoRay Inc (ISR) gained over ‎254.38‎% at $1.88 in pre-market ‎trading on Wednesday after receiving clearance from U.S. Food and Drug Administration (FDA) ‎for the use of C4 Imaging’s Sirius positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds.

    Top Upgrades & Downgrades

    KeyBanc turned bullish on Cirrus Logic Inc. (CRUS), upgrading the stock to “Overweight” and assigning a $100.0 price target, representing potential upside of 15.79% from Tuesday’s close.

    MetLife Inc. (MET) has won the favor of Piper Sandler’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $52.0, suggesting 11.47% additional upside for the stock.

    J.B. Hunt Transport Services Inc. (JBHT) received an upgrade from analysts at Citigroup. They changed their rating on JBHT to Buy from Neutral in a recently issued research note.

    Earlier Wednesday RBC Capital reduced its rating on Perrigo Company plc (PRGO) stock to Sector Perform from Outperform and assigned the price target to $49.

    Wells Fargo analysts reduced their investment ratings, saying in research reports covered by the media that its rating for American Electric Power Company, Inc. (AEP) has been changed to Equal-Weight from Overweight and the new price target is set at $88.

    Analysts at B. Riley Securities downgraded Kratos Defense & Security Solutions Inc. (KTOS)’s stock to Neutral from Buy Wednesday.

    Latest Insider Activity

    fuboTV Inc. (FUBO) 10% Owner COMCAST CORP announced the sale of shares taking place on Dec 31 at $30.06 for some 500,000 shares. The total came to more than $15.03 million.

    Intercept Pharmaceuticals Inc. (ICPT) CFO and Treasurer Kapadia Sandip sold on Jan 05 a total 23,764 shares at $24.47 on average. The insider’s sale generated proceeds of almost $53663.

    Gritstone Oncology Inc. (GRTS) Director Woiwode Thomas declared the purchase of shares taking place on Dec 30 at $3.71 for some 1,347,709 shares. The transaction amount was around $5.0 million.

    Tonix Pharmaceuticals Holding Corp. (TNXP) Chief Executive Officer LEDERMAN SETH bought on Dec 30 a total 118,267 shares at $0.68 on average. The purchase cost the insider an estimated $23,800.

    Important Earnings

    Top US earnings releases scheduled for today include The Simply Good Foods Company (NASDAQ:SMPL). It will announce its Nov 2020 financial results. The company is expected to report earnings of $0.21 per share from revenues of $209.72M in the three-month period.

    Analysts expect The Greenbrier Companies Inc. (NYSE:GBX) to report a net income (adjusted) of -$0.07 per share, when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Nov 2020 is predicted to come in at $481.03M.

    Resources Connection Inc. (RGP), due to announce earnings after the market closes today, is expected to report earnings of $0.19 per share from revenues of $153.32M recently concluded three-month period.